EUDA Health Holdings (EUDA) Return on Sales (2022 - 2023)

EUDA Health Holdings' (EUDA) quarterly Return on Sales came in at 0.46% in Q2 2023, down 45.0% year-on-year from 0.83% in Q2 2022, and down 3125.1% on a QoQ basis from 0.01% in Q1 2023.

EUDA Health Holdings (EUDA) Return on Sales (2022 - 2023) Analysis & Trends

EUDA Health Holdings (EUDA) has 2 years of Return on Sales data on file, last reported at 0.46% in Q2 2023.

  • On a quarterly basis, Return on Sales fell 45.0% year-over-year to 0.46% in Q2 2023; TTM through Jun 2023 was 0.03%, a N/A change from a year earlier, with the FY2025 full-year figure at 0.0%, down 1.0% from the prior year.
  • Return on Sales for Q2 2023 stood at 0.46%, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Sales for EUDA reached as high as 0.0% in Q1 2022 and fell as low as 0.46% in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Colliers International 4,798.15 Bn 4,797.86 Bn - 0.00%
2 IHS Holding 60.96 Bn 61.13 Bn 231.80 0.00%
3 KE Holdings 53.48 Bn 50.59 Bn 661.06 Mn 0.00%
4 Cbre 39.71 Bn 39.92 Bn 1.85 Bn 0.00%
5 Jones Lang Lasalle 14.96 Bn 14.65 Bn - 0.00%
6 Costar 11.08 Bn 9.80 Bn 701.00 Mn 0.00%
7 Compass 7.92 Bn 7.44 Bn 2.31 Bn 0.00%
8 FirstService 6.01 Bn 6.28 Bn 480.66 Mn 0.00%
9 Opendoor Technologies 3.69 Bn 2.69 Bn 72.00 Mn 0.00%
10 EUDA Health Holdings 2.22 Mn 1.86 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -0.46%
Mar 31, 2023 -0.01%
Jun 30, 2022 -0.01%
Mar 31, 2022 0.00%